OA Plan to Appease White House?

Scientific publishers come up with a scheme to disseminate publicly funded research in response to a directive from President Obama’s top science advisor.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, LOOZRBOYOpen-access advocates rejoiced this past February when John Holdren, director of the White House’s Office of Science and Technology Policy (OSTP), issued a memo stating that all federal agencies funding scientific research must make those papers freely available to the public within 1 year of publication in a journal. But how to implement such a sweeping plan, which called for federal science agencies to find a system for making published, taxpayer-funded research open access by August 22? Well, a consortium of scientific publishers thinks it has the solution, and its plan circumvents the need for each agency to construct and manage a full text database modeled on the National Institutes of Health’s PubMed Central.

The project is called the Clearinghouse for the Open Research of the United States (CHORUS), and it’s being organized in part by commercial and nonprofit journals that belong to the Association of American Publishers, a publishing trade organization and lobbying group. The details of the plan are not yet crystal clear, but CHORUS would make the full text of publically funded papers available on the journal’s own websites instead of directing users to repositories like PubMed Central.

In CHORUS’s opening notes, publishers have started to index papers supported by funding from federal agencies in a brand new database called FundRef, which is in beta.

Fred Dylla, executive director of the American Institute of Physics—which publishes Applied Physics Letters, Biomicrofluidics, and other titles—told ScienceInsider that CHORUS ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies